top of page

Subtle%20Shapes%20Transparent_edited.png

INSIGHTS

Insights

Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.

Search

Meghan Mullooly

Jul 20, 2021

How Product Acquisition Impacts Patient Support Offerings: Buy and Bill vs. Specialty Pharmacy

Travis Jones

Jun 22, 2021

How Pharmaceutical Companies Deliver Successful Patient Access Launch Strategies for Biosimilars

Anna Beth Lindenmeyer

May 25, 2021

Have you done your research?

Joshua Burns

Mar 4, 2021

The Smart Way to Approach Pharmaceutical Reimbursement HUB Innovation

Team Archbow

Dec 1, 2020

How Healthy are Your Pharmaceutical Patient Access Programs?

Team Archbow

Oct 21, 2020

The Five Data Sets Every Specialty Pharmaceutical Needs Today

Tami Stowe

Mar 3, 2020

Pharma Reimbursement HUBs: To Audit, or not to Audit?

Team Archbow

Jul 23, 2019

What to know before you migrate a Patient Service Program

Kevin Cast

May 29, 2019

Why “Demand Chain” is the new “Supply Chain” in Cell and Gene Therapy

Justine Hughes

Mar 12, 2019

Build a Better Patient

Sheryl Heinle

Jul 16, 2018

Quality: pharma’s forgotten differentiator

Team Archbow

Jun 12, 2018

How to know if your program needs to be optimized

Team Archbow

May 21, 2018

5 things I wish I knew before my first pharma technology project

Team Archbow

May 7, 2018

The three hottest topics in specialty today

DeWayne Manning

Apr 2, 2018

Pharma Digitalization 101 | PharmaDCX

Katie Rapp

Mar 12, 2018

Best practices for pharma internal project communications

Sheryl Heinle

Jan 30, 2018

Blue Ocean thinking creates REMS opportunity

Team Archbow

Jan 12, 2018

10 pharma and biotech trends to watch in 2018

Sheryl Heinle

Dec 8, 2017

Differentiate your brand with a Blue Ocean approach

Douglas Bock

Oct 31, 2017

How to avoid a FrankenLaunch

bottom of page